Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCELLULAR AND MOLECULAR

Distinct Recognition of OX1 and OX2Receptors by Orexin Peptides

Sylwia Ammoun, Tomas Holmqvist, Ramin Shariatmadari, Hendrica B. Oonk, Michel Detheux, Marc Parmentier, Karl E. O. Åkerman and Jyrki P. Kukkonen
Journal of Pharmacology and Experimental Therapeutics May 2003, 305 (2) 507-514; DOI: https://doi.org/10.1124/jpet.102.048025
Sylwia Ammoun
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomas Holmqvist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ramin Shariatmadari
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hendrica B. Oonk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Detheux
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Parmentier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl E. O. Åkerman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jyrki P. Kukkonen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

In this study, we have compared the abilities of orexin-A and orexin-B and variants of orexin-A to activate different Ca2+responses (influx and release) in human OX1 and OX2 receptor- expressing Chinese hamster ovary cells. Responses mediated by activation of both receptor subtypes with either orexin-A or -B were primarily dependent on extracellular Ca2+, suggesting similar activation of Ca2+influx as we have previously shown for orexin-A and OX1receptors. Amino acid-wise truncation of orexin-A reduced its ability to activate OX1 and OX2 receptors, but the response mediated by the OX2 receptor was more resistant to truncation than the response mediated by the OX1 receptor. We also performed a sequential replacement of amino acids 14 to 26 with alanine in the truncated orexin-A variant orexin-A14–33. Replacement of the same amino acids produced a fall in the potency for each receptor subtype, but the reduction was less prominent for the OX2 receptor. The most marked reduction was produced by the replacement of Leu20, Asp25, and His26 with alanine. Interestingly, extracellular Ca2+ dependence of responses to some of the mutated peptides was different from those of orexin-A and -B. The mutagenesis also suggests that although the determinants required from orexin-A for binding to and activation of the receptor are highly conserved between the orexin receptor subtypes, the OX2receptor requires fewer determinants. This might in part explain why orexin-B has the affinity and potency equal to orexin-A for this subtype, although it has 10- to 100-fold lower affinity and potency for the OX1 receptor.

Footnotes

  • This study was supported by European Union contracts ERBBIO4CT960699 and QLG3-CT-2002-00826, by the Swedish Medical Research Council, the Cancer Research Fund of Sweden, the Lars Hierta Foundation, the Göran Gustafsson Foundation, the Novo Nordisk Foundation, the Academy of Finland, and the Sigrid Jusélius Foundation.

  • DOI: 10.1124/jpet.102.048025

  • Abbreviations:
    [Ca2+]e
    extracellular free calcium concentration
    [Ca2+]i
    intracellular free calcium concentration
    CHO
    Chinese hamster ovary
    CNS
    central nervous system
    Δ[Ca2+]i
    change in [Ca2+]i([Ca2+]i/stimulated − [Ca2+]i/basal)
    EC50
    concentration producing half-maximal response
    EGTA
    ethylene glycol-bis(β-aminoethyl ether)N,N,N′,N′-tetraacetic acid
    IP3
    inositol 1,4,5-trisphosphate
    N
    the number of batches of cells for the measurements
    pEC50
    −log(EC50)
    probenecid
    p-(dipropylsulfamoyl)benzoic acid
    TBM
    TES-buffered medium
    TES
    2-([2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino) ethanesulfonic acid
    • Received December 13, 2002.
    • Accepted January 14, 2003.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 305 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 305, Issue 2
1 May 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Distinct Recognition of OX1 and OX2Receptors by Orexin Peptides
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCELLULAR AND MOLECULAR

Distinct Recognition of OX1 and OX2Receptors by Orexin Peptides

Sylwia Ammoun, Tomas Holmqvist, Ramin Shariatmadari, Hendrica B. Oonk, Michel Detheux, Marc Parmentier, Karl E. O. Åkerman and Jyrki P. Kukkonen
Journal of Pharmacology and Experimental Therapeutics May 1, 2003, 305 (2) 507-514; DOI: https://doi.org/10.1124/jpet.102.048025

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCELLULAR AND MOLECULAR

Distinct Recognition of OX1 and OX2Receptors by Orexin Peptides

Sylwia Ammoun, Tomas Holmqvist, Ramin Shariatmadari, Hendrica B. Oonk, Michel Detheux, Marc Parmentier, Karl E. O. Åkerman and Jyrki P. Kukkonen
Journal of Pharmacology and Experimental Therapeutics May 1, 2003, 305 (2) 507-514; DOI: https://doi.org/10.1124/jpet.102.048025
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Chlorogenic Acid Inhibits Breast Cancer Metastasis
  • SNAP25 and mGluRs Control Pathological Tau Release
  • N-Stearoylethanolamine Inhibits Platelet Reactivity
Show more Cellular and Molecular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics